Product Information
EVOTAZ 300 MG-150 MG TABLET is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $52.0162 per EA under NDC 00003364111. Its NADAC has been published 549 times since Jun 17, 2015.
FDA first approved this application on Jan 29, 2015.
Strength
300; 150 mg/1; mg/1
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003364111
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATAZANAVIR SULFATE; COBICISTATApproval Type
New Drug (NDA)
FDA Application
NDA206353FDA Approved
1/29/2015
On Market Since
1/29/2015
Pharmacological Classes
Price Statistics
The NADAC for EVOTAZ 300 MG-150 MG TABLET has been published 549 times since Jun 17, 2015, and over the history we have for it it has risen 15.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $52.0162 per EA |
|---|---|
| All-time high | $52.1041 (Feb 15, 2017) |
| All-time low | $44.9016 (Jul 22, 2015) |
| 52-week high | $52.0310 |
| 52-week low | $51.9394 |
| Median price | $51.9275 |
| Average price | $51.1631 |
| Largest weekly change | +7.9% (Jan 13, 2016) |
| Weeks tracked | 549 |
| Tracking since | Jun 17, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the atazanavir and cobicistat market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EVOTAZ 300 MG-150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVOTAZ 300 MG-150 MG TABLET, manufactured by E.R. Squibb & Sons, L.L.C., is $52.0162 per EA (NDC 00003364111), effective Aug 19, 2026.
How has the price of EVOTAZ 300 MG-150 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVOTAZ 300 MG-150 MG TABLET has risen 15.5%. It has been tracked across 549 weekly CMS publications since Jun 17, 2015.
What are the highest and lowest recorded NADAC prices for EVOTAZ 300 MG-150 MG TABLET?
Since Jun 17, 2015, the NADAC for EVOTAZ 300 MG-150 MG TABLET has ranged from a low of $44.9016 (Jul 22, 2015) to a high of $52.1041 (Feb 15, 2017), with a median of $51.9275 per EA.
Are there cheaper alternatives to EVOTAZ 300 MG-150 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of EVOTAZ 300 MG-150 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures EVOTAZ 300 MG-150 MG TABLET?
EVOTAZ 300 MG-150 MG TABLET (NDC 00003364111) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.